Search

Your search keyword '"Mirthe E van der Valk"' showing total 16 results
Start Over Author "Mirthe E van der Valk" Publisher elsevier bv
16 results on '"Mirthe E van der Valk"'

1. Su1801 One Simple Question Is Sufficient for Measuring Medication Adherence in Inflammatory Bowel Disease Patients Using Self-Report

Author

M Jeroen, Mariëlle Romberg-Camps, Herma Fidder, Cyriel Y. Ponsioen, Peter D. Siersema, Paul C. van de Meeberg, Christien J. van der Woude, Andrea Van Der Meulen, Mike van der Have, Dirk J. de Jong, Adriaan A. van Bodegraven, Mirthe E. van der Valk, Bas Oldenburg, Reinoud Vermeijden, Mirjam Severs, Cees H. M. Clemens, Marie J. Pierik, Peter Zuithoff, Gerard Dijkstra, Nofel Mahmmod, and Marie-Josée J. Mangen

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine, Medication adherence, Simple question, Intensive care medicine, business, medicine.disease, Self report, Inflammatory bowel disease
Published
2016
Full Text
View/download PDF

2. Sa1944 Non-Adherence to Medical Therapy Is Associated With Hospitalizations and the Development of Active Disease in Inflammatory Bowel Disease

Author

Gerard Dijkstra, Reinoud Vermeijden, Mirthe E. van der Valk, Mirjam Severs, Cees H. M. Clemens, Marie-Josée J. Mangen, Dirk J. de Jong, Christien J. van der Woude, Peter Zuithoff, Marie J. Pierik, Bas Oldenburg, Adriaan A. van Bodegraven, Peter D. Siersema, Paul C. van de Meeberg, Nofel Mahmmod, Andrea Van Der Meulen, Mike van der Have, Cyriel Y. Ponsioen, Herma Fidder, M Jeroen, and Mariëlle Romberg-Camps

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Active disease, Gastroenterology, medicine, medicine.disease, business, Inflammatory bowel disease, Medical therapy, Non adherence
Published
2016
Full Text
View/download PDF

3. Sa1945 Lower Quality of Life, More Active Disease and Increased Healthcare Costs Due to Non-Adherence in Inflammatory Bowel Disease

Author

Christien J. van der Woude, Herma Fidder, Gerard Dijkstra, Bas Oldenburg, Cyriel Y. Ponsioen, Marie J. Pierik, Cees H. M. Clemens, Mirthe E. van der Valk, Nofel Mahmmod, Marie-Josée J. Mangen, Mirjam Severs, Peter D. Siersema, Paul C. van de Meeberg, Andrea Van Der Meulen, Mike van der Have, Peter Zuithoff, M Jeroen, Dirk J. de Jong, Mariëlle Romberg-Camps, Adriaan A. van Bodegraven, and Reinoud Vermeijden

Subjects
0301 basic medicine, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine.disease, Inflammatory bowel disease, Non adherence, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Quality of life (healthcare), Health care, Active disease, medicine, Physical therapy, 030211 gastroenterology & hepatology, Intensive care medicine, business
Published
2016
Full Text
View/download PDF

4. Tu1243 Evolution of IBD-Related Costs Over Two Years of Follow up: Increase of Anti-TNF α Therapy Related Costs With a Decline of Hospitalization Costs

Author

Gerard Dijkstra, Peter D. Siersema, Adriaan A. van Bodegraven, Paul C. van de Meeberg, Marie-Josée J. Mangen, Nofel Mahmmod, Christien J. van der Woude, Marie J. Pierik, Cees H. M. Clemens, Bas Oldenburg, J.R. Vermeijden, Mirjam Severs, Dirk J. de Jong, Mike van der Have, Clemens Bolwerk, Cyriel Y. Ponsioen, Mariëlle Romberg-Camps, Herma Fidder, Andrea E. van der Meulen de Jong, Jeroen M. Jansen, Max Leenders, and Mirthe E. van der Valk

Subjects
Oncology, medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, Medicine, business, Anti tnf α therapy
Published
2015
Full Text
View/download PDF

5. Su1299 Smoking Is Associated With Extra-Intestinal Manifestations in Inflammatory Bowel Disease

Author

Herma Fidder, Adriaan A. van Bodegraven, Nofel Mahmmod, Christien J. van der Woude, Max Leenders, Peter D. Siersema, Paul C. van de Meeberg, Bas Oldenburg, Mirthe E. van der Valk, Andrea E. van der Meulen de Jong, Gerard Dijkstra, Mariëlle Romberg-Camps, Jeroen M. Jansen, Dirk J. de Jong, J.R. Vermeijden, Cyriel Y. Ponsioen, Cees H. M. Clemens, Mirjam Severs, Marie J. Pierik, Clemens Bolwerk, Marie-Josée J. Mangen, Mike van der Have, and Sanne J.H. van Erp

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, medicine.disease, business, Inflammatory bowel disease
Published
2015
Full Text
View/download PDF

6. Su1300 Healthcare Expenditures for Inflammatory Bowel Disease Peak in Patients With a Short Disease Duration

Author

Cees H. M. Clemens, Christien J. van der Woude, Marie J. Pierik, Dirk J. de Jong, Bas Oldenburg, Marie-Josée J. Mangen, Max Leenders, Herma Fidder, Adriaan A. van Bodegraven, Jeroen M. Jansen, Andrea E. van der Meulen de Jong, Clemens Bolwerk, Nofel Mahmmod, Mariëlle Romberg-Camps, Mike van der Have, Mirthe E. van der Valk, Gerard Dijkstra, Cyriel Y. Ponsioen, Mirjam Severs, Peter D. Siersema, Paul C. van de Meeberg, and J.R. Vermeijden

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Disease duration, Health care, Gastroenterology, medicine, In patient, business, medicine.disease, Inflammatory bowel disease
Published
2015
Full Text
View/download PDF

7. Sa1155 Smoking Is Associated With Higher Healthcare Costs in IBD Patients, Primarily Due to More Frequent Anti-TNFα Use

Author

Christien J. van der Woude, Jeroen M. Jansen, Clemens Bolwerk, Andrea E. van der Meulen de Jong, Bas Oldenburg, Mirthe E. van der Valk, Max Leenders, J.R. Vermeijden, Cyriel Y. Ponsioen, Mirjam Severs, Cees H. M. Clemens, Gerard Dijkstra, Dirk J. de Jong, Herma Fidder, Marie J. Pierik, Peter D. Siersema, Paul C. van de Meeberg, Mike van der Have, Adriaan A. van Bodegraven, Mariëlle Romberg-Camps, Marie-Josée J. Mangen, and Nofel Mahmmod

Subjects
medicine.medical_specialty, Pediatrics, Hepatology, business.industry, Emergency medicine, Health care, Gastroenterology, medicine, business
Published
2015
Full Text
View/download PDF

8. Su1326 Self-Reported Disability Index in Inflammatory Bowel Disease: Results From a Large Dutch Prospective Cohort

Author

Mariëlle Romberg-Camps, Cees H. M. Clemens, Cyriel Y. Ponsioen, Gerard Dijkstra, Reinoud Vermeijden, Herma Fidder, Dirk J. de Jong, Nofel Mahmmod, Jeroen M. Jansen, Marie J. Pierik, Peter D. Siersema, Paul C. van de Meeberg, Adriaan A. van Bodegraven, Max Leenders, Christien J. van der Woude, Adrian A. Kaptein, Andrea E. van der Meulen de Jong, Bas Oldenburg, Clemens Bolwerk, Mirthe E. van der Valk, and Mike van der Have

Subjects
medicine.medical_specialty, Index (economics), Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, Retrospective cohort study, business, Prospective cohort study, medicine.disease, Inflammatory bowel disease
Published
2014
Full Text
View/download PDF

9. Su1327 Healthcare Costs and Their Predictors in Inflammatory Bowel Disease: Two Year Results From the COIN study

Author

Marie-Josée J. Mangen, Christien J. van der Woude, Marie J. Pierik, Reinoud Vermeijden, Nofel Mahmmod, Cyriel Y. Ponsioen, Mariëlle Romberg-Camps, Jeroen M. Jansen, Dirk J. de Jong, Herma Fidder, Max Leenders, Adriaan A. van Bodegraven, Gerard Dijkstra, Clemens Bolwerk, Cees H. M. Clemens, Mirthe E. van der Valk, Andrea E. van der Meulen de Jong, and Paul C. van de Meeberg

Subjects
medicine.medical_specialty, Hepatology, business.industry, Health care, Gastroenterology, Physical therapy, Medicine, business, Intensive care medicine, medicine.disease, Inflammatory bowel disease
Published
2014
Full Text
View/download PDF

10. Sa1285 Is There a Difference in Quality of Life and Costs Between Ulcerative Colitis Patients With a Pouch or an Ileostomy?

Author

Christien J. van der Woude, Herma Fidder, Claudia Rogge-Wolf, Bas Oldenburg, Marie-Josée J. Mangen, Reinoud Vermeijden, Jeroen M. Jansen, Cyriel Y. Ponsioen, Gerard Dijkstra, Peter D. Siersema, Nofel Mahmmod, Paul C. van de Meeberg, Mariëlle Romberg-Camps, Adriaan A. van Bodegraven, Dirk J. de Jong, Cees H. M. Clemens, Mirthe E. van der Valk, Marie J. Pierik, and Martijn G.H. van Oijen

Subjects
medicine.medical_specialty, Hepatology, business.industry, General surgery, medicine.medical_treatment, Gastroenterology, Primary care, medicine.disease, Ulcerative colitis, Ileostomy, Quality of life (healthcare), Internal medicine, medicine, University medical, business
Abstract

P194 Is there a difference in quality of life or costs between ulcerative colitis patients with a pouch or an ileostomy? M. Van der Valk1 *, M.-J. Mangen2, G. Dijkstra3, A. van Bodegraven4, H. Fidder1, D. de Jong5, M. Pierik6, C.J. van der Woude7, M. Romberg-Camps8, C. Clemens9, J. Jansen10, P. van de Meeberg11, N. Mahmmod12, C. Ponsioen13, C. Rogge-Wolf14, R. Vermeijden15, P. Siersema1, M. Van Oijen1, B. Oldenburg16. 1University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht, Netherlands, 2University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, Netherlands, 3University Medical Center Groningen, Gastroenterology and Hepatology, Groningen, Netherlands, 4VU University Medical Center, Gastroenterology, Amsterdam, Netherlands, 5Universitair Medisch Centrum St Radboud, Afd Maag Darm Leverziekten, Nijmegen, Netherlands, 6Maastricht University Medical Center, Dept of Gastroenterology, Maastricht, Netherlands, 7Erasmus Medical Center, Department of Gastroenterology & Hepatology, Rotterdam, Netherlands, 8Orbis Medical Center, Gastroenterology and Hepatology, Sittard, Netherlands, 9Diaconessenhuis, Gastroenterology and Hepatology, Leiden, Netherlands, 10Onze Lieve Vrouwe Gasthuis, Gastroenterology and Hepatology, Amsterdam, Netherlands, 11Slingeland Hospital, Gastroenterology and Hepatology, Doetinchem, Netherlands, 12Antonius Hospital, Gastroenterology and Hepatology, Nieuwegein, Netherlands, 13Academic Medical Center, Gastroenterology and Hepatology, Amsterdam, Netherlands, 14Reinier de Graaf Gasthuis, Gastroenterology and Hepatology, Delft, Netherlands, 15Meander Medical Center, Gastroenterology and Hepatology, Amersfoort, Netherlands, 16University Medical Centre Utrecht, Department of Gastroenterology, Utrecht, Netherlands

Published
2012
Full Text
View/download PDF

11. Sa1284 Anti TNF-α Therapy is a Major Cost Driver in Inflammatory Bowel Disease: Results From the COIN study

Author

Peter D. Siersema, Paul C. van de Meeberg, Reinoud Vermeijden, Marie-Josée J. Mangen, Herma Fidder, Christien J. van der Woude, Nofel Mahmmod, Bas Oldenburg, Marie J. Pierik, Jeroen M. Jansen, Claudia Rogge-Wolf, Gerard Dijkstra, Mariëlle Romberg-Camps, Cyriel Y. Ponsioen, Cees H. M. Clemens, Mirthe E. van der Valk, Martijn G.H. van Oijen, Dirk J. de Jong, and Adriaan A. van Bodegraven

Subjects
medicine.medical_specialty, Hepatology, business.industry, Cost driver, Internal medicine, Immunology, Gastroenterology, medicine, medicine.disease, business, Inflammatory bowel disease, Anti tnf α therapy
Published
2012
Full Text
View/download PDF

13. Crohn's Disease Patients Treated With Adalimumab Benefit From Co-Treatment With Immunomodulators: Results From a Nationwide Study in the Netherlands

Author

Mirthe E. van der Valk, Martijn G.H. van Oijen, Peter D. Siersema, Marije J. Ammerlaan, and Bas Oldenburg

Subjects
medicine.medical_specialty, Crohn's disease, Hepatology, business.industry, Internal medicine, Gastroenterology, Adalimumab, medicine, business, medicine.disease, medicine.drug, Surgery
Published
2011
Full Text
View/download PDF

14. Work Disability in Inflammatory Bowel Disease: First Results From the COIN study

Author

Martijn G.H. van Oijen, Bas Oldenburg, Mirthe E. van der Valk, Marie-Josée J. Mangen, and Peter D. Siersema

Subjects
medicine.medical_specialty, Hepatology, business.industry, Work disability, Gastroenterology, Disease, Odds ratio, medicine.disease, Logistic regression, Inflammatory bowel disease, Ulcerative colitis, Indirect costs, Quality of life, Internal medicine, medicine, business
Abstract

Introduction: Chronic work disability is an important medical and social consequence of inflammatory bowel disease (IBD) and is associated with a substantial economic burden to society. To date, only few data exist on factors predicting work disability. Aim: The study on ‘Costs Of IBD in the Netherlands’ (COIN) aims to assess work disability, quality of life and direct and indirect costs in a large cohort of IBD patients in the Netherlands and to determine demographic, disease and work specific factors associated with these endpoints. Here, we report the baseline characteristics of the first 942 patients enrolled in this trial. Methods: Between October 1st 2010 and December 1st 2010, a total of 15,000 patients with IBD were invited by post to participate in the COIN study, which consists of a baseline and follow up web-based questionnaire every 3 months for a total of 2 years. The baseline data includes questions on demographic, disease and work specific characteristics, and a health-related quality of life questionnaire (HRQoL). All data from questionnaires ‘returned’ until November 25th 2010 were analyzed. Descriptive statistics were used to characterize patients with Crohn's disease (CD) and Ulcerative colitis (UC). Multivariate logistic regression analyses were performed to assess the association between chronic work disability and disease characteristics. Results: A total of 942 patients were included, of which 537 (57%) CD patients (35% males, mean age 46 ±14 years) and 405 (43%) UC patients (52% males, mean age 50±13 years). Patients were included from university medical centers (n=487; 52%) and general hospitals (n=455; 48%). Twenty six percent (n=139) of CD patients were chronically disabled, compared to 17% (n=68) of UC patients (Odds ratio (OR) 0.58, 95%CI 0.42-0.80). Disabled CD and UC patients had a lower EQ-5D as compared to employed patients (0.67 ±0.24 vs. 0.87 ±0.14, p 40 years (adjusted (adj.) OR 2.02; 95%CI 1.213.36), smoking (adj. OR 1.69, 95% 1.02-2.81), disease duration (adj. OR 1.02, 95%CI 1.001-1.05) and endostomy (adj. OR 2.73, 95%CI 1.49-5.00) were independently associated with work disability. In UC patients, only age > 40 was associated with disability (adj. OR 2.20, 95%CI 1.01-4.79). Conclusion: In conclusion, almost a quarter of all IBD patients have disabling disease. This is more pronounced in CD than UC. Patients at risk for work disability are those at older age (>40 years) and with a low quality of life in both CD and UC, whereas in CD patients, also smoking, a longer disease duration and an endostomy are involved.

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results